Mucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and ...

Mucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and ...

Alzinova AB (publ) (ticker: ALZ) today announces that the final analysis of data from the Phase 1b clinical study with the vaccine candidate ALZ-101, which included patients with early Alzheimer's dis ...

Although both protect from infection, the humanized antibody reduces immunogenicity and enhances therapeutic effect when used in humans, a major translational step. Early tests show that VX-01 is ...

Keymed Biosciences Inc. (HKEX: 02162) announced its annual results of 2024, along with a corporate update.  Rapid development of our pipeline products Stapokibart (CM310) (IL-4R? antibody) Three new ...

CDI Labs Canada Inc., a leading provider of services for proteome-wide antibody profiling and target identification, today announced the launch of its Technology Access Program for custom peptide ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Presented preclinical non-human primate (NHP) data at the 20th Congress of European Crohn’s and Colitis Organization in Inflammatory Bowel ...